MATINAS BIOPHARMA HOLDINGS, INC. Stock-Based Compensation
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Stock-Based Compensation of $104.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $104.00K, a 56.30% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $113.00K, a 64.13% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $217.00K, a 11.07% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $253.00K, a 73.78% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $1.02M, a 67.98% decline from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $3.19M, a 35.43% decline from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $4.95M, a 5.36% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $5.23M, a 21.81% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 32 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $104.00K 10-Q · filed 2026-08-13 | $217.00K 10-Q · filed 2026-08-13 | $434.00K derived: sum of 3 quarters · filed 2026-08-13 | $687.00K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $113.00K 10-Q · filed 2026-05-08 | $330.00K derived: sum of 2 quarters · filed 2026-05-08 | $583.00K derived: sum of 3 quarters · filed 2026-05-08 | $821.00K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $470.00K derived: sum of 2 quarters · filed 2026-03-31 | $708.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.02M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $253.00K 10-Q · filed 2025-11-10 | $491.00K derived: sum of 2 quarters · filed 2026-08-13 | $806.00K 10-Q · filed 2025-11-10 | $1.05M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $238.00K 10-Q · filed 2026-08-13 | $553.00K 10-Q · filed 2026-08-13 | $797.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.76M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $315.00K 10-Q · filed 2026-05-08 | $559.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.52M derived: sum of 3 quarters · filed 2026-05-08 | $2.52M derived: sum of 4 quarters · filed 2026-05-08 | |||||
| 2024-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.21M derived: sum of 2 quarters · filed 2026-03-31 | $2.20M derived: sum of 3 quarters · filed 2026-03-31 | $3.19M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $965.00K 10-Q · filed 2025-11-10 | $1.96M derived: sum of 2 quarters · filed 2025-11-10 | $2.95M 10-Q · filed 2025-11-10 | $4.22M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2024-06-30 | $991.00K 10-Q · filed 2025-08-14 | $1.99M 10-Q · filed 2025-08-14 | $3.26M derived: sum of 3 quarters · filed 2025-08-14 | $4.45M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $995.00K 10-Q · filed 2025-05-15 | $2.27M derived: sum of 2 quarters · filed 2025-05-15 | $3.46M derived: sum of 3 quarters · filed 2025-05-15 | $4.67M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $2.47M derived: sum of 2 quarters · filed 2025-04-15 | $3.68M derived: sum of 3 quarters · filed 2025-04-15 | $4.95M 10-K · filed 2025-04-15 | |||||
| 2023-09-30 | $1.20M 10-Q · filed 2024-11-13 | $2.40M derived: sum of 2 quarters · filed 2024-11-13 | $3.68M 10-Q · filed 2024-11-13 | $5.02M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $1.21M 10-Q · filed 2024-08-14 | $2.48M 10-Q · filed 2024-08-14 | $3.82M derived: sum of 3 quarters · filed 2024-08-14 | $5.23M derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | $1.27M 10-Q · filed 2024-05-09 | $2.61M derived: sum of 2 quarters · filed 2024-05-09 | $4.03M derived: sum of 3 quarters · filed 2024-05-09 | $5.24M derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.75M derived: sum of 2 quarters · filed 2024-03-27 | $3.97M derived: sum of 3 quarters · filed 2024-03-27 | $5.23M 10-K · filed 2024-03-27 | |||||
| 2022-09-30 | $1.41M 10-Q · filed 2023-11-08 | $2.63M derived: sum of 2 quarters · filed 2023-11-08 | $3.89M 10-Q · filed 2023-11-08 | $3.89M 10-Q · filed 2022-11-02 | $4.96M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $1.22M 10-Q · filed 2023-08-09 | $2.48M 10-Q · filed 2023-08-09 | $2.47M 10-Q · filed 2022-08-11 | $3.55M derived: sum of 3 quarters · filed 2023-08-09 | $4.61M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-10 | $1.26M 10-Q · filed 2022-05-12 | $2.33M derived: sum of 2 quarters · filed 2023-05-10 | $3.40M derived: sum of 3 quarters · filed 2023-05-10 | $4.45M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $2.14M derived: sum of 2 quarters · filed 2023-03-15 | $3.19M derived: sum of 3 quarters · filed 2023-03-15 | $4.29M 10-K · filed 2023-03-15 | $4.29M 10-K · filed 2022-03-08 | ||||
| 2021-09-30 | $1.06M 10-Q · filed 2021-11-08 | $2.12M derived: sum of 2 quarters · filed 2022-08-11 | $3.22M 10-Q · filed 2022-11-02 | $4.44M derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-06-30 | $1.06M 10-Q · filed 2022-08-11 | $2.16M 10-Q · filed 2022-08-11 | $3.38M derived: sum of 3 quarters · filed 2022-08-11 | $4.33M derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | $1.10M 10-Q · filed 2022-05-12 | $2.32M derived: sum of 2 quarters · filed 2022-05-12 | $3.27M derived: sum of 3 quarters · filed 2022-05-12 | $4.22M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $1.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $2.17M derived: sum of 2 quarters · filed 2022-03-11 | $3.12M derived: sum of 3 quarters · filed 2022-03-11 | $4.56M 10-K/A · filed 2022-03-11 | |||||
| 2020-09-30 | $953.00K 10-Q · filed 2021-11-08 | $1.90M derived: sum of 2 quarters · filed 2021-11-08 | $3.34M 10-Q · filed 2021-11-08 | $4.03M derived: sum of 4 quarters · filed 2021-11-08 | |||||
| 2020-06-30 | $945.00K 10-Q · filed 2021-08-10 | $2.39M 10-Q · filed 2021-08-10 | $3.08M derived: sum of 3 quarters · filed 2021-08-10 | $3.75M derived: sum of 4 quarters · filed 2021-08-10 | |||||
| 2020-03-31 | $1.45M 10-Q · filed 2021-05-10 | $2.13M derived: sum of 2 quarters · filed 2021-05-10 | $2.81M derived: sum of 3 quarters · filed 2021-05-10 | $3.63M derived: sum of 4 quarters · filed 2021-05-10 | |||||
| 2019-12-31 | $687.79K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $1.36M derived: sum of 2 quarters · filed 2021-03-29 | $2.18M derived: sum of 3 quarters · filed 2021-03-29 | $2.99M 10-K · filed 2021-03-29 | |||||
| 2019-09-30 | $671.00K 10-Q · filed 2019-11-13 | $1.49M derived: sum of 2 quarters · filed 2019-11-13 | $2.30M 10-Q · filed 2020-11-06 | $3.33M derived: sum of 4 quarters · filed 2020-05-11 | |||||
| 2019-06-30 | $822.00K 10-Q · filed 2019-08-13 | $1.63M 10-Q · filed 2020-08-10 | $2.66M derived: sum of 3 quarters · filed 2020-05-11 | $3.16M derived: sum of 4 quarters · filed 2020-05-11 | |||||
| 2019-03-31 | $804.46K 10-Q · filed 2020-05-11 | $1.83M derived: sum of 2 quarters · filed 2020-05-11 | $2.34M derived: sum of 3 quarters · filed 2020-05-11 | $2.89M derived: sum of 4 quarters · filed 2020-05-11 | |||||
| 2018-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $1.54M derived: sum of 2 quarters · filed 2020-03-09 | $2.09M derived: sum of 3 quarters · filed 2020-03-09 | $3.83M 10-K · filed 2020-03-09 | |||||
| 2018-09-30 | $505.00K 10-Q · filed 2019-11-13 | $1.05M derived: sum of 2 quarters · filed 2019-11-13 | $2.80M 10-Q · filed 2019-11-13 | $4.16M derived: sum of 4 quarters · filed 2019-11-13 | |||||
| 2018-06-30 | $550.00K 10-Q · filed 2019-08-13 | $2.30M 10-Q · filed 2019-08-13 | $3.66M derived: sum of 3 quarters · filed 2019-08-13 | $4.21M derived: sum of 4 quarters · filed 2019-08-13 | |||||
| 2018-03-31 | $1.75M 10-Q · filed 2019-05-13 | $3.11M derived: sum of 2 quarters · filed 2019-05-13 | $3.66M derived: sum of 3 quarters · filed 2019-05-13 | $3.97M derived: sum of 4 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.91M derived: sum of 2 quarters · filed 2019-04-01 | $2.23M derived: sum of 3 quarters · filed 2019-04-01 | $3.60M 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | $551.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $867.52K derived: sum of 2 quarters · filed 2018-11-09 | $2.24M 10-Q · filed 2018-11-09 | $2.48M derived: sum of 4 quarters · filed 2018-11-09 | |||||
| 2017-06-30 | $315.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.69M 10-Q · filed 2018-08-09 | $1.93M derived: sum of 3 quarters · filed 2018-08-09 | $2.41M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $1.37M 10-Q · filed 2018-05-09 | $1.62M derived: sum of 2 quarters · filed 2018-05-09 | $2.10M derived: sum of 3 quarters · filed 2018-05-09 | $2.50M derived: sum of 4 quarters · filed 2018-05-09 | |||||
| 2016-12-31 | $244.79K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $725.43K derived: sum of 2 quarters · filed 2018-03-16 | $1.13M derived: sum of 3 quarters · filed 2018-03-16 | $1.52M 10-K · filed 2018-03-16 | |||||
| 2016-09-30 | $480.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $881.41K derived: sum of 2 quarters · filed 2017-11-14 | $1.27M 10-Q · filed 2017-11-14 | $1.70M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2016-06-30 | $400.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $793.47K 10-Q · filed 2017-08-08 | $1.22M derived: sum of 3 quarters · filed 2018-03-16 | $1.65M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2016-03-31 | $392.69K 10-Q · filed 2017-05-15 | $819.51K derived: sum of 2 quarters · filed 2018-03-16 | $1.25M derived: sum of 3 quarters · filed 2018-03-16 | $1.65M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2015-12-31 | $426.82K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $858.61K derived: sum of 2 quarters · filed 2018-03-16 | $1.26M derived: sum of 3 quarters · filed 2018-03-16 | $1.59M 10-K · filed 2018-03-16 | |||||
| 2015-09-30 | $431.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $832.87K derived: sum of 2 quarters · filed 2016-11-14 | $1.17M 10-Q · filed 2016-11-14 | $1.69M derived: sum of 4 quarters · filed 2016-11-14 | |||||
| 2015-06-30 | $401.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $733.76K 10-Q · filed 2016-08-15 | $1.26M derived: sum of 3 quarters · filed 2016-08-15 | $2.16M derived: sum of 4 quarters · filed 2016-08-15 | |||||
| 2015-03-31 | $332.68K 10-Q · filed 2016-05-13 | $860.24K derived: sum of 2 quarters · filed 2016-05-13 | $1.76M derived: sum of 3 quarters · filed 2016-05-13 | $2.03M derived: sum of 4 quarters · filed 2016-05-13 | |||||
| 2014-12-31 | $527.55K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.43M derived: sum of 2 quarters · filed 2016-03-30 | $1.70M derived: sum of 3 quarters · filed 2016-03-30 | $1.97M 10-K · filed 2016-03-30 | |||||
| 2014-09-30 | $899.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $1.17M derived: sum of 2 quarters · filed 2015-11-10 | $1.45M 10-Q · filed 2015-11-10 | $1.59M derived: sum of 4 quarters · filed 2015-11-10 | |||||
| 2014-06-30 | $273.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $547.59K 10-Q · filed 2015-08-13 | $695.31K derived: sum of 3 quarters · filed 2015-08-13 | $873.33K derived: sum of 4 quarters · filed 2015-08-13 | |||||
| 2014-03-31 | $273.82K 10-Q · filed 2015-05-15 | $421.54K derived: sum of 2 quarters · filed 2015-05-15 | $599.56K derived: sum of 3 quarters · filed 2015-05-15 | $599.56K derived: sum of 4 quarters · filed 2015-05-15 | $491.25K 10-Q · filed 2014-06-06 | ||||
| 2013-12-31 | $147.72K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $325.74K derived: sum of 2 quarters · filed 2015-03-31 | $325.74K derived: sum of 3 quarters · filed 2015-03-31 | $325.74K 10-K · filed 2015-03-31 | |||||
| 2013-09-30 | $178.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $178.02K derived: sum of 2 quarters · filed 2014-11-14 | $178.02K 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | |||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |